Last August, Sana Biotechnology opened a new 80,000-square-foot manufacturing plant in an old AT&T call center in Bothell, Washington. The Seattle-based startup, which manufactures engineered cells used as medicines for cancer, diabetes, and autoimmune disease patients, had been working on the project for more than a year. The facility was expected to create hundreds of new jobs and bring manufacturing in-house.